Phoebe Cancer Center at Phoebe Putney Memorial Hospital

The Phoebe Cancer Center at Phoebe Putney Memorial Hospital is located in Albany, Georgia. The center is fully accredited by the American College of Surgeons Commission on Cancer as a Community Hospital Comprehensive Cancer Program. The center is also accredited by the American College of Radiology (ACR). There are eleven physicians practicing at the Phoebe Cancer Center, including the following specialties: hematology oncology, radiation oncology and surgical oncology. Services offered include: counseling, support groups, nutrition, oncology wellness program, lymphedema clinic, breast cancer nurse navigator, transportation options, light house, inpatient unit, pastoral care, hospice, financial assistance, Carlton Breast Health Center and tumor registry. Each patient at the Phoebe Cancer Center has an entire team working for them, including doctors, certified oncology nurses, pharmacists, lab analysts, counselors and other medical professionals. The center is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers.

Treatment Sites in Georgia

Clinical Trials in Georgia

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Cancer Type: Unknown Primary

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of Tecemotide Versus Placebo in Subjects With Completed Concurrent Chemo-radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Cancer Type: Lung Cancer

A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes
Cancer Type: Myelodysplastic Syndromes (MDS)

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Cancer Type: Breast Cancer

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer

Phase III Randomized Study of Standard Adjuvant Endocrine Therapy With Versus Without Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive, and HER2-Negative Breast Cancer
Cancer Type: Breast Cancer
Study Coordinator: Rita Cox, BSN - (229) 312-0405


Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Cancer Type: Breast Cancer

Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Cancer Type: Breast Cancer

S1400 Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Cancer Type: Lung Cancer